PRESS RELEASE published on 12/09/2024 at 07:30, 4 months ago Inside Information / News release on accounts, results Poxel reports financial results for first half 2024 including revenue of EUR 1.162 million and net loss of EUR 7.258 million, provides outlook following non-adoption of financial delegations at AGM, upcoming General Meeting to adopt new resolutions Financial Results Revenue Outlook General Meeting Poxel
BRIEF published on 11/29/2024 at 07:35, 4 months 10 days ago Poxel Combined General Meeting: Results and Decisions Shareholders Resolutions Financial Communication General Assembly Poxel
PRESS RELEASE published on 11/29/2024 at 07:30, 4 months 10 days ago Inside Information / Other news releases Poxel announces successful Annual General Meeting results, including voting statistics and approved resolutions. Details available on the company's website Annual General Meeting Financial Statements Voting Results Metabolic Disorders Poxel
BRIEF published on 11/04/2024 at 20:10, 5 months 5 days ago Evolution of the number of shares and voting rights of Poxel in 2024 Share Capital Voting Rights Actions AMF Biopharmaceutical
BRIEF published on 10/11/2024 at 07:35, 5 months 29 days ago Poxel Releases 2023 Universal Registration Document Corporate Governance Annual Financial Report CSR Report Poxel 2023 Registration Document
PRESS RELEASE published on 10/11/2024 at 07:30, 5 months 29 days ago Annual financial and audit reports / Terms of availability of the annual financial report Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
BRIEF published on 10/03/2024 at 18:35, 6 months 6 days ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 6 months 9 days ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 6 months 9 days ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 7 months ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
Published on 04/09/2025 at 20:10, 22 minutes ago Taranis Quantifies Hydrothermal Alteration System at Thor to Improve Targeting for 2025 Deep Exploration Drilling
Published on 04/09/2025 at 18:00, 2 hours 32 minutes ago BrooQLy Inc. (BRQL) dba Dynamic Aerospace Systems Appoints FedEx Leader in Logistics to Board of Directors
Published on 04/09/2025 at 15:15, 5 hours 17 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 04/09/2025 at 15:00, 5 hours 32 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt During the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 15:00, 5 hours 32 minutes ago The Cree Trappers Association, the Cree Hunters Economic Security Board and Mining & Exploration Companies Approve 2025 Funding to Continue the Reconstruction of Cabins Burnt during the 2023 Forest Fires, James Bay, Quebec
Published on 04/09/2025 at 20:20, 12 minutes ago Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 14 minutes ago EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 1 hour 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:34, 1 hour 58 minutes ago PolyPeptide announces results of the annual General Meeting 2025
Published on 04/09/2025 at 18:02, 2 hours 29 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 04/09/2025 at 18:59, 1 hour 32 minutes ago Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 hour 34 minutes ago Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 2 hours 47 minutes ago COGELEC : 2024 full-year results and Q1 2025 revenue.
Published on 04/09/2025 at 17:40, 2 hours 52 minutes ago COGELEC : Statement on the total number of shares and voting rights.
Published on 04/09/2025 at 08:00, 12 hours 32 minutes ago Museum Studio becomes a majority shareholder in Lord Cultural Resources
